Maternal L-carnitine supplementation ameliorates renal underdevelopment and epigenetic changes in male mice offspring due to maternal smoking

Clin Exp Pharmacol Physiol. 2019 Feb;46(2):183-193. doi: 10.1111/1440-1681.13038. Epub 2018 Nov 22.

Abstract

Objectives: Epidemiological and animal studies showed that L-carnitine (LC) supplementation can ameliorate oxidative stress-induced tissues damage. We have previously shown that maternal cigarette smoke exposure (SE) can increase renal oxidative stress in newborn offspring with postnatal kidney underdevelopment and renal dysfunction in adulthood, which were normalised by LC administration in the SE dams during pregnancy. Exposure to an adverse intrauterine environment may lead to alteration in the epigenome, a mechanism by which adverse prenatal conditions increase the susceptibility to chronic disease later in life. The current study aimed to determine whether maternal SE induces epigenetic changes in the offspring's kidney are associated with renal underdevelopment, and the protective effect of maternal LC supplementation.

Method: Female Balb/c mice (7 weeks) were exposed to cigarette smoke (SE) or air (Sham) for 6 weeks prior to mating, during gestation and lactation. A subgroup of the SE dams received LC via drinking water (SE + LC, 1.5 mmol/L) throughout gestation and lactation. Male offspring were studied at postnatal day (P)1, P20, and 13 weeks.

Results: Maternal SE altered the expression of renal development markers glial cell line-derived neurotrophic factor and fibroblast growth factor 2, which were associated with increased renal global DNA methylation and DNA methyltransferase 1 mRNA expression at birth. These disorders were reversed by maternal LC administration.

Conclusion: The effect of maternal SE on renal underdevelopment involves global epigenetic alterations from birth, which can be prevented by maternal LC supplementation.

Keywords: antioxidant; global methylation; kidney development; maternal smoking.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carnitine / pharmacology*
  • Cell Proliferation / drug effects
  • Dietary Supplements*
  • Epigenesis, Genetic / drug effects*
  • Female
  • Fibroblasts / drug effects
  • Fibroblasts / pathology
  • Glial Cell Line-Derived Neurotrophic Factor / metabolism
  • Kidney / drug effects*
  • Kidney / growth & development
  • Kidney / metabolism
  • Kidney / pathology
  • Male
  • Maternal Exposure / adverse effects*
  • Methylation / drug effects
  • Mice
  • Mice, Inbred BALB C
  • Oxidative Stress / drug effects
  • Pregnancy
  • Prenatal Exposure Delayed Effects / genetics
  • Prenatal Exposure Delayed Effects / pathology
  • Prenatal Exposure Delayed Effects / physiopathology
  • Prenatal Exposure Delayed Effects / prevention & control*
  • Signal Transduction / drug effects
  • Smoking / adverse effects*

Substances

  • Glial Cell Line-Derived Neurotrophic Factor
  • Carnitine